Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

about

Treating Negative Symptoms in Schizophrenia: an Update Decreased Expression of IFNG-AS1, IFNG and IL-1B Inflammatory Genes in Medicated Schizophrenia and Bipolar Patients.

P2860

Q26744805-D7CF8D03-FD05-4D85-BB47-D7AC0ADCA64A Q47651631-B3FE549C-DF00-4FAF-A27C-8DCB19E5B5A5

P2860

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

Item

http://www.wikidata.org/entity/Q47964432

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@en

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@nl

type

Item

label

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@en

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@nl

prefLabel

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@en

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

@nl

P1476

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia

@en

P2093

Svetlana Alexandrovna Sergeeva

http://www.w3.org/2001/XMLSchema#string

Tamara Parfenovna Vetlugina

http://www.w3.org/2001/XMLSchema#string

Tatiana Ivanovna Nevidimova

http://www.w3.org/2001/XMLSchema#string

Valentina Borisovna Nikitina

http://www.w3.org/2001/XMLSchema#string

P2860

The Effect of Long-Term Antipsychotic Treatment on Prolactin

Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models.

Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited

Differentiation of effector CD4 T cell populations (*)

Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.

Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.

A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.

Application of ultralow doses of antibodies to interferon-gamma in complex therapy of bacterial infections and prophylaxis of bacterial complications.

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.

Neuropsychiatric disorders related to interferon and interleukins treatment.

P304

149-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/NEU.2015.60

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arkady V. Semke

Olga Anatolyevna Lobacheva

P577

2015-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26567593

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

about

P2860

P2860

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921